GARUDA THERAPEUTICS

garuda-therapeutics-logo

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

GARUDA THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2021-01-01

Address:
Natick, Massachusetts, United States

Country:
United States

Website Url:
http://www.garudatx.com

Total Employee:
51+

Status:
Active

Email Addresses:
info@garudatx.com

Total Funding:
72 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Mobile Non Scaleable Content


Similar Organizations

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

gentibio-logo

GentiBio

GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kyverna-therapeutics-logo

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

octant-bio-logo

Octant Bio

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

taysha-gene-therapies-logo

Taysha Gene Therapies

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

wugen-logo

Wugen

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies


Current Advisors List

carl-l-gordon_image

Carl L. Gordon Board Member @ Garuda Therapeutics
Board_member
2021-09-01

shaan-gandhi_image

Shaan Gandhi Board Member @ Garuda Therapeutics
Board_member
2021-09-01

rahul-singhvi_image

Rahul Singhvi Board Member @ Garuda Therapeutics
Board_member
2021-09-01

eric-aguiar_image

Eric Aguiar Board Member @ Garuda Therapeutics
Board_member
2021-09-01

Current Employees Featured

not_available_image

Dhvanit Shah
Dhvanit Shah Founder, President, and Chief Executive Officer @ Garuda Therapeutics
Founder, President, and Chief Executive Officer

james-desiderio_image

James Desiderio
James Desiderio Chief Regulatory Officer @ Garuda Therapeutics
Chief Regulatory Officer
2022-03-01

Founder


not_available_image

David Scadden

not_available_image

Dhvanit Shah

not_available_image

Sean Morrison

Investors List

mass-general-brigham-ventures_image

Mass General Brigham Ventures

Mass General Brigham Ventures investment in Series A - Garuda Therapeutics

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Series A - Garuda Therapeutics

northpond-ventures_image

Northpond Ventures

Northpond Ventures investment in Series A - Garuda Therapeutics

sectoral-asset-management_image

Sectoral Asset Management

Sectoral Asset Management investment in Series A - Garuda Therapeutics

monashee-investment_image

Monashee Investment Management

Monashee Investment Management investment in Series A - Garuda Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Garuda Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - Garuda Therapeutics

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series A - Garuda Therapeutics

resilience-e701_image

Resilience

Resilience investment in Series A - Garuda Therapeutics

Official Site Inspections

http://www.garudatx.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.81 K

  • Host name: 74-208-236-97.elastic-ssl.ui-r.com
  • IP address: 74.208.236.97
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Garuda Therapeutics"

Garuda Therapeutics - Crunchbase Company Profile

Contact Email info@garudatx.com Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases. It seeks to …See details»

Garuda Therapeutics Closes $50 Million Series A-1 Financing

Mar 4, 2025 ir@garudatx.com. Recommended Reading. March 03, 2025 07:30 ET | Source: Garuda Therapeutics. Garuda Therapeutics Announces the Appointment of Avanish Vellanki …See details»

Garuda Therapeutics Information - RocketReach

Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the …See details»

Garuda Therapeutics Named “Overall Cell Biology Company of

LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life …See details»

Garuda Therapeutics 2025 Company Profile | PitchBook

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; AU-2022252247-A1: Pluripotent stem cell-derived hematopoietic lineagesSee details»

Garuda Therapeutics Closes $50 Million Series A-1 Financing

Mar 4, 2025 About Garuda Therapeutics. Garuda Therapeutics seeks to eliminate the need for stem cell donors for blood stem cell transplants. Garuda’s proprietary off-the-shelf …See details»

Garuda Therapeutics: Revenue, Worth, Valuation & Competitors …

About Garuda Therapeutics. Garuda Therapeutics is a Biotech related company founded in 2021 and based in Cambridge with 82 employees an estimated revenue of $12.7M, and. It has 10 …See details»

Garuda Therapeutics - Craft

Garuda Therapeutics has 5 employees at their 1 location and $72 m in total funding,. See insights on Garuda Therapeutics including office locations, competitors, revenue, financials, …See details»

Garuda Therapeutics - LinkedIn

Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the …See details»

Garuda - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 28, 2025 Garuda - Developer of stem cell-based therapies to treat multiple diseases. Raised a total funding of $182M over 3 rounds from 11 investors. Founded by David Scadden and …See details»

Garuda Therapeutics - Overview, News & Similar companies

Jan 9, 2024 View Garuda Therapeutics (www.garudatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»

Garuda Therapeutics Company Overview, Contact Details

Feb 7, 2023 Be The Match BioTherapies partnered with Garudatx on May 24th '23. Be The Match BioTherapies®, an organization offering solutions for companies developing and …See details»

Garuda Therapeutics Launches with $72 Million Series A Financing

Sep 23, 2021 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf, durable blood stem cell therapies, launched today with an …See details»

Garuda Therapeutics - Company Profile & Staff Directory

Garuda Therapeutics is a Biotechnology company located in Cambridge, US with 60 employees. Access Garuda Therapeutics's email format and Garuda Therapeutics staff directory for direct …See details»

Be The Match BioTherapies® To Provide Robust Cell Therapy

MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Be The Match BioTherapies ®, an organization offering solutions for companies developing and commercializing cell and gene …See details»

Garuda Therapeutics - VentureRadar

"The platform for generating off-the-shelf, self-renewing blood stem cells is designed to provide patients with rapid and broad access to consistent, durable, HLA-matched transgene-free …See details»

Associate Director / Director – Regulatory CMC – Garuda

Please contact careers@garudatx.com to share your resume and learn more. Facebook; Twitter; LinkedIn; E-Mail; Comments are closed. Contact Info 22 Strathmore Road Natick, MA 01760 …See details»

Garuda Therapeutics to Present at 41st Annual J.P. Morgan …

Jan 5, 2023 Company Roger Sawhney, Chief Financial Officer roger.sawhney@garudatx.com. Media MacDougall Advisors Megan Prock McGrath mmcgrath@macdougall.bio or (781) 235 …See details»

Scale Up Scientist / Senior Scientist – Process Development

Scale Up Scientist / Senior Scientist – Process Development. Garuda Therapeutics, a biotechnology company focused on developing off-the-shelf human hematopoietic stem cell …See details»

Pluripotent Stem Cell Scientist / Senior Scientist – Process ...

Natick, MA 01760 USA E-Mail: careers@garudatx.com. Apply Now " *" indicates required fields. Name * First Last. Email * Phone * Upload Resume. Accepted file types: pdf, doc, docx, Max. …See details»

linkstock.net © 2022. All rights reserved